Axcelead DDP has already been engaged in multiple drug discovery projects in the neuroscience area to identify candidate compounds since October 2022. Acadia and Axcelead DDP have entered into the ...
The Los Angeles area is seeing a troubling increase in local dengue fever cases, health officials warned Wednesday.
Pharmaceutical company Lupin has announced a non-exclusive patent licence agreement with Takeda Pharmaceutical for the ...
Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...
Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...
OSAKA, Japan & CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Sep 18, 2024-- ...
1don MSN
Under the terms of this agreement, Takeda has granted Lupin non-exclusive patent licensing rights to commercialise Vonoprazan ...
Lupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialize Vonoprazan tablets ...
ArriVent BioPharma is developing a treatment for non-small cell lung cancer. Click here to read more about AVBP stock and ...
Arzeda, a protein design startup that generates new enzymes for industrial, agricultural and other applications, announced a ...
Zacks.com on MSN2d
TAK vs. STVN: Which Stock Is the Better Value Option?Investors interested in stocks from the Medical - Drugs sector have probably already heard of Takeda Pharmaceutical Co. (TAK) and Stevanato Group (STVN). But which of these two stocks is more ...
SEATTLE, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback